A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2004
11/24/2004	CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/24/2004	CN1176714C Method and composition for treating prostate cancer
11/24/2004	CN1176690C Medicine for treating chronic nephritis
11/24/2004	CN1176651C N-(3-benzofuryl) urea derivative
11/23/2004	US6822112 Prostaglandin derivatives
11/23/2004	US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders
11/23/2004	US6822097 Compounds and methods of uses
11/23/2004	US6822002 Use of L-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use
11/23/2004	US6821988 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
11/23/2004	US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants
11/23/2004	US6821978 Xanthine phosphodiesterase V inhibitors
11/23/2004	US6821977 Antidiabetic agents
11/23/2004	US6821970 Useful for treating diseases wherein modulation of 5-ht activity is desired; nervous system disorders
11/23/2004	US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation
11/23/2004	US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes.
11/23/2004	US6821731 Expression analysis of FKBP nucleic acids and polypeptides useful in the diagnosis of prostate cancer
11/23/2004	CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents
11/23/2004	CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin
11/23/2004	CA2059052C Phenylimidazolidines, process for their preparation, their application as medicaments and pharmaceutical compositions containing them
11/18/2004	WO2004099189A1 Methyl indoles and methyl pyrrolopyridines as alph-1 adrenergic agonists
11/18/2004	WO2004098637A1 Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency
11/18/2004	WO2004098611A1 Fortifier
11/18/2004	WO2004098586A1 Use of phenoxyacetic acid derivatives for treating hyperactive bladder
11/18/2004	WO2004071381A3 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds
11/18/2004	WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42)
11/18/2004	WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents
11/18/2004	WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/18/2004	WO2002086087A3 Cytokine protein family
11/18/2004	US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases
11/18/2004	US20040229947 Method of treating hyperactive bladder using phenoxyacetic acid derivatives
11/18/2004	US20040229932 osteoarthritis; little to no intrinsic estrogenicity; antagonizes the effects of 17 beta -estradiol with minimal uterine stimulation; bone loss inhibitor
11/18/2004	US20040229912 Polymeric delivery formulations of leuprolide with improved efficacy
11/18/2004	US20040229885 Xanthine phosphodiesterase V inhibitors
11/18/2004	US20040229882 dipeptide or tripeptide MC-1R and MC-4R agonists
11/18/2004	US20040229872 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity
11/18/2004	US20040229870 Certain alkylene diamine-substituted heterocycles
11/18/2004	US20040229845 Modified PSMA ligands and uses related thereto
11/18/2004	US20040229834 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
11/18/2004	US20040229833 Therapeutic use of cis-element decays in vivo
11/18/2004	US20040229823 For use in therapy of growth metabolic disorders
11/18/2004	US20040228906 Use of buprenorphine for the manufacture of a transdermal delivery device for the treatment of urinary incontinence, especially urge incontinence
11/18/2004	DE10315917A1 Hochreine Basen von 3,3-Diphenylpropylaminmonoestern High purity bases of 3,3-Diphenylpropylaminmonoestern
11/17/2004	EP1477479A1 Process for the preparation of the D-(-)-tartrate salt of 1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-YL)-1-propanol
11/17/2004	EP1477183A1 Botulinum toxins for modulating cholinergic controlled secretions
11/17/2004	EP1477178A2 Health supplements containing phyto-oestrogens, analogues or metabolites thereof
11/17/2004	EP1477175A1 Fused pyridazine derivative compounds and drugs containing the compounds as the active ingredient
11/17/2004	EP1476574A2 RNA INTERFERENCE MEDIATED INHIBITION OF TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR (IGF-1R) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/17/2004	EP1476545A2 Aggrecanase molecules
11/17/2004	EP1476469A1 MONOCLONAL ANTIBODIES AGAINST EXTRACELLULAR LOOPS OF C5aR
11/17/2004	EP1476466A1 Management of mucosal viscosity by tff monomer peptides
11/17/2004	EP1476458A2 Rna interference mediated inhibition of platelet derived growth factor (pdgf) and platelet derived growth factor receptor (pdgfr) gene expression using short interfering nucleic acid (sina)
11/17/2004	EP1476438A1 Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
11/17/2004	EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds
11/17/2004	EP1476185A2 Antibodies to cd40
11/17/2004	EP1476167A1 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
11/17/2004	EP1476158A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476157A1 Nicotinamide derivatives useful as pde4 inhibitors
11/17/2004	EP1476146A1 Use of cyclooxygenase inhibitors and antimuscarinic agents for the treatment of incontinence
11/17/2004	EP1476143A1 Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
11/17/2004	EP1476136A1 Pharmaceutical composition comprising n-((1-n-butyl-4-piperidinyl)menthyl)-3,4-dihydro-2h-(1,3)oxazino(3,2-a)indole-10-carboxamide or salt and process therefor comprising dry granulation
11/17/2004	EP1272468B1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands
11/17/2004	EP1214323B1 Indoloazepines as vasopressin receptor antagonists
11/17/2004	EP1144409B1 Phenyl urea and phenyl thiourea derivatives
11/17/2004	EP1137667B1 Analogues of glp-1
11/17/2004	EP1109809B1 Pyrroloquinolines for treatment of obesity
11/17/2004	EP1087762B1 Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects
11/17/2004	EP0907658B1 Neuropeptide y agonists
11/17/2004	CN1547584A Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives and related treatment methods
11/17/2004	CN1547583A 多环鸟嘌呤磷酸二酯酶v抑制剂 Polycyclic guanine phosphodiesterase inhibitor v
11/17/2004	CN1547579A 4-(phenyl-piperdin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/17/2004	CN1547482A Use of POLY-GLU,TYR and T cells treated therewith for neuroprotective therapy
11/17/2004	CN1547477A Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
11/17/2004	CN1547468A The use of anthroquinones in the treatment of kidney disease
11/17/2004	CN1547466A Extended release oral dosage form
11/17/2004	CN1547464A Prolonged release bioadhesive therapeutic systems
11/17/2004	CN1546150A Chinese traditional medicine for treating prostate disease
11/17/2004	CN1546145A Pure Chinese traditional medicine tablet for treating prostate proliferation of blood stasis blocking the bladder syndrome
11/17/2004	CN1546134A Prescription and preparing process and preparation of Wugen capsule
11/17/2004	CN1546129A Preparing technics of composition of Guizhi and Fuling and its use
11/17/2004	CN1546108A Medicine for treating chronic nephritis and its preparing process
11/17/2004	CN1546105A Natural botanic drink for treating prostatitis
11/17/2004	CN1546072A Chinese traditional medicine for treating prostate disease and nephritis and preparing process thereof
11/17/2004	CN1546031A Alfuzosin dripping pills and its preparation
11/17/2004	CN1175872C Drug for treating urinary system disease
11/17/2004	CN1175865C Composite medicine for treating lumbodynia and method for preparing medicinal cup thereof
11/17/2004	CN1175833C Ointment for treating prostatitis and its usage
11/16/2004	US6818750 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation or inflammatory disorders
11/16/2004	US6818745 For diagnosis/treatment of tumors; drug screening of antitumor agents; metastatic-tumor excreted phosphaturic-element (mepe/phosphatonin)
11/16/2004	US6818651 Antiinflammatory, antiasthmatic, skin, and autoimmune disorders; crohn*s disease, ulcerative colitis, conjuctivitis, multiple sclerosis, and rheumatoid arthritis; chronic obstructive pulmonary disease
11/16/2004	US6818645 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders
11/16/2004	US6818640 2-imino-1,3-thiazine derivatives
11/16/2004	US6818638 Melvinolin derivatives
11/16/2004	US6818632 Protein tyrosine kinase and protein serin/threonine kinase inhibitory activity; anticancer agents; treating chemotherapy induced alopecia
11/16/2004	US6818621 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
11/16/2004	US6818615 Antitumor, anticancer agents; synergistic mixture
11/16/2004	US6818445 Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/11/2004	WO2004096812A1 Fused pyrimidine derivative
11/11/2004	WO2004096806A1 Fused imidazole derivative
11/11/2004	WO2004096804A1 Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
11/11/2004	WO2004096775A1 4,4-difluoro-1,2,3,4-tetrahydro-5h-1-benzazepine derivative or salt thereof

1 ... 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 ... 562